MedlinePlus: NIH's Public Health Information Resource

MedlinePlus is a free, publicly accessible health information service produced by the National Library of Medicine (NLM), a component of the National Institutes of Health. The resource serves patients, families, and the general public by translating peer-reviewed biomedical research and clinical knowledge into plain-language content spanning thousands of health topics. Understanding what MedlinePlus covers, how its information is curated, and when it is the appropriate tool — versus more specialized NIH databases — is essential for anyone navigating the federal government's public health information infrastructure, an overview of which is available on the nihauthority.com homepage.

Definition and scope

MedlinePlus is NLM's consumer health portal, distinct from PubMed and other NIH research databases that are designed for clinicians and researchers working with primary literature. The service hosts content on more than 1,000 health topics organized by condition, body system, demographic group, and life stage. Beyond topic pages, MedlinePlus provides an online medical encyclopedia, a drug and supplement database, a medical dictionary, and curated links to clinical trials listed on ClinicalTrials.gov.

The scope of MedlinePlus is deliberately broad rather than deep. It does not publish original research; instead, NLM editors select, translate, and organize information drawn from authoritative federal health agencies — including the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and individual NIH institutes such as the National Cancer Institute and the National Institute on Aging. Content is available in both English and Spanish, reflecting the NLM's mandate to serve linguistically diverse populations across the United States.

How it works

MedlinePlus operates through a structured editorial workflow maintained by NLM medical librarians and subject specialists. The process follows five core stages:

1. Topic identification — Librarians identify high-demand health topics based on search patterns, public health priorities, and gaps in plain-language federal content.
2. Source selection — Only content from federal agencies, academic medical centers, and recognized professional health organizations is eligible for inclusion. Commercial or advertising-supported sources are excluded by policy (NLM MedlinePlus Editorial Policy).
3. Plain-language adaptation — Where NLM produces original summaries, they are written to a reading level accessible to the general public, typically aligned with a sixth- to eighth-grade comprehension target.
4. Multilingual translation — Spanish-language versions are maintained in parallel with English content, not generated automatically.
5. Ongoing review and currency — Topic pages are reviewed on a scheduled basis; links to external resources are verified to prevent link rot and ensure continued accuracy.

The underlying technology platform is maintained by NLM's Office of Communications and Public Liaison, and the site is indexed by major search engines, making it one of the most frequently surfaced federal health resources in organic search results. The drug information database within MedlinePlus is powered by the American Society of Health-System Pharmacists (ASHP), providing standardized monographs for prescription and over-the-counter medications.

Common scenarios

MedlinePlus serves three distinct user groups whose needs overlap but differ in depth:

Patients and caregivers use MedlinePlus after receiving a new diagnosis to understand terminology, treatment options, and what questions to raise with a clinician. A patient recently diagnosed with Type 2 diabetes, for example, can access NLM-curated summaries of the condition, links to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) clinical guidance, and relevant clinical trials actively recruiting participants.

Health educators and public health communicators use MedlinePlus as a vetted source for patient handout materials and community education programs, particularly because the content is federal government-produced and therefore in the public domain. This is a meaningful distinction from commercially produced health content, which carries copyright restrictions.

Librarians and reference professionals rely on MedlinePlus to answer consumer health reference questions in public and academic library settings. The NLM explicitly supports this use case by providing training resources through its National Network of Libraries of Medicine (NNLM), which operates through regional offices covering all 50 states.

Decision boundaries

Knowing when MedlinePlus is the appropriate resource — and when a different NIH tool is needed — requires understanding the distinction between consumer-facing and research-facing platforms.

MedlinePlus vs. PubMed: MedlinePlus is appropriate when the need is for synthesized, plain-language health information accessible to a non-specialist audience. PubMed indexes more than 35 million citations from biomedical journals (NLM PubMed overview) and is designed for users who can interpret primary research literature, assess study design, and evaluate statistical findings. The two platforms are complementary; MedlinePlus topic pages frequently link to relevant PubMed searches for users who want to explore underlying research.

MedlinePlus vs. NIH institute-specific resources: Individual NIH institutes — such as the National Institute of Mental Health or the National Heart, Lung, and Blood Institute — maintain their own patient education portals with condition-specific depth. MedlinePlus aggregates and cross-links to these institute resources but does not replicate the full clinical depth available at the institute level. A user seeking detailed NHLBI guidance on a specific cardiac rehabilitation protocol would benefit from going directly to NHLBI's site rather than remaining within MedlinePlus.

MedlinePlus vs. ClinicalTrials.gov: MedlinePlus links to relevant clinical trials but does not host trial records. Users who need to search active trials by eligibility criteria, location, or intervention type must use ClinicalTrials.gov directly. MedlinePlus serves as an entry point and contextual explainer, not a trial registry.

The boundaries also extend to what MedlinePlus explicitly does not do: it does not provide personalized medical advice, does not offer diagnostic tools, and does not replace consultation with a licensed healthcare provider. This boundary is maintained both editorially and in site policy, consistent with NLM's role as an information infrastructure agency rather than a clinical services provider. This positioning aligns with the broader NIH health information mission for patients and the agency's mandate to make biomedical knowledge publicly accessible.